🔎 Trials Near Me

Home › Multiple Myeloma › North Carolina › Winston-Salem

Pag-aaral pangklinika para sa Multiple Myeloma sa Winston-Salem, NC

14 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Winston-Salem (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Nagre-recruitPhase 3
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07391657

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Nagre-recruitPhase 2
  • Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07149857

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

Nagre-recruitPhase 2
  • Wake Forest University, School of Medicine Dept. of Internal Medicine, Division of Hematology Oncology, Winston-Salem
Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06052826

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Nagre-recruitPhase 3
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05552222

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Nagre-recruitPhase 1/2
  • Wake Forest Baptist Health /ID# 271294, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06953960

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

Nagre-recruitPhase 3
  • Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07555938

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Nagre-recruitPhase 3
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07764978

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

Nagre-recruitPhase 1/2
  • Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT06892522

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 1
  • Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05650632

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Nagre-recruitPhase 1
  • Wake Forest University Health Sciences, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT05137054

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

Nagre-recruitPhase 3
  • GSK Investigational Site, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT06679101

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Nagre-recruitObservasyonal na pag-aaral
  • Wake Forest Baptist Health, Winston-Salem
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT01890486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Nagre-recruitPhase 1/2
  • Atrium Wake Forest Baptist Medical Center, Winston-Salem
Edad 12 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04988555

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Nagre-recruitPhase 1/2
  • Atrium Health Wake Forest Baptist, Winston-Salem
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2025 · NCT06119685

Pag-aaral para sa Multiple Myeloma sa ibang lungsod

Iba pang pag-aaral sa Winston-Salem

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.